trending Market Intelligence /marketintelligence/en/news-insights/trending/8td22lzWceBDmq_axxNe4Q2 content esgSubNav
In This List

AngioDynamics sues C.R. Bard for allegedly violating federal antitrust laws

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


AngioDynamics sues C.R. Bard for allegedly violating federal antitrust laws

AngioDynamics Inc. filed a lawsuit against C. R. Bard Inc., alleging that its competitor violated federal antitrust laws by tying the sales of its tip location devices with its own peripherally inserted central catheters, or PICCs.

"By doing so, customers who want to buy Bard's tip location systems must also buy Bard's line of PICCs, preventing hospitals and other medical providers from purchasing AngioDynamics' superior BioFlo PICCs," the company claimed in its lawsuit filed with the U.S. District Court for the Northern District of New York.

Tip locators detect the ideal spot for catheter insertion to administer drugs directly into a patient's bloodstream.

Angiodynamics claims that Bard's practice of preloading its catheter tip placement devices onto its own catheter harms competition and limits access to patients.

The company is seeking to end Bard's "violation of the antitrust laws" and recover damages for its losses.

AngioDynamics is represented by law firm Boies Schiller Flexner LLP.